相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transport mechanism of Mycobacterium tuberculosis MmpL/S family proteins and implications in pharmaceutical targeting
Shuang Ma et al.
BIOLOGICAL CHEMISTRY (2020)
Flavonoids as Novel Efflux Pump Inhibitors and Antimicrobials Against Both Environmental and Pathogenic Intracellular Mycobacterial Species
Julia Solnier et al.
MOLECULES (2020)
In Silico Chemogenomics Drug Repositioning Strategies for Neglected Tropical Diseases
Carolina Horta Andrade et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae
Gurkamaljit Kaur et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
Ekta Lachmandas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Molecular modelling and competitive inhibition of a Mycobacterium tuberculosis multidrug-resistance efflux pump
Joao Luis Rheingantz Scaini et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis
Sabine Schuster et al.
MOLECULES (2019)
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
Chandrasekaran Padmapriyadarsini et al.
BMJ OPEN (2019)
Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M-tuberculosis
Jiayun Liu et al.
FRONTIERS IN MICROBIOLOGY (2019)
In Vitro Study of Stepwise Acquisition of rv0678 and atpE Mutations Conferring Bedaquiline Resistance
Nabila Ismail et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Mycobacterium tuberculosis Rv0191 is an efflux pump of major facilitator superfamily transporter regulated by Rv1353c
Xue Li et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method
Pankul Kotwal et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2019)
A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis
Karen Cohen et al.
EXPERT OPINION ON DRUG SAFETY (2019)
Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India
Anshika Narang et al.
PLOS ONE (2019)
Comparison Of drrA And drrB Efflux Pump Genes Expression In Drug-Susceptible And -Resistant Mycobacterium tuberculosis Strains Isolated From Tuberculosis Patients In Iran
Azar Dokht Khosravi et al.
INFECTION AND DRUG RESISTANCE (2019)
Mycobacterium tuberculosis Rv1473 is a novel macrolides ABC Efflux Pump regulated by WhiB7
Wei Duan et al.
FUTURE MICROBIOLOGY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Toxicity of Doxorubicin (Dox) to different experimental organ systems
Arivalagan Pugazhendhi et al.
LIFE SCIENCES (2018)
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo
Anila K. Madiraju et al.
NATURE MEDICINE (2018)
Multidrug efflux pumps: structure, function and regulation
Dijun Du et al.
NATURE REVIEWS MICROBIOLOGY (2018)
In vitro combinatory activity of piperine and anti-tuberculosis drugs in Mycobacterium tuberculosis
Laise Adriane Hegeto et al.
TUBERCULOSIS (2018)
Identification of Novel Mycobacteria Inhibitors Against Mycobacterial Protein Kinase G
Yuichi Kanehiro et al.
FRONTIERS IN MICROBIOLOGY (2018)
Challenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
Diana Machado et al.
FRONTIERS IN MICROBIOLOGY (2018)
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics
Diana Machado et al.
FUTURE MICROBIOLOGY (2018)
Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria
Ming-Chia Lee et al.
PLOS ONE (2018)
Identification of Enolase as the Target of 2-Aminothiazoles in Mycobacterium tuberculosis
Heather H. Wescott et al.
FRONTIERS IN MICROBIOLOGY (2018)
A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma
Elias A. El-Habr et al.
ACTA NEUROPATHOLOGICA (2017)
Isocitrate dehydrogenase mutations in myeloid malignancies
B. C. Medeiros et al.
LEUKEMIA (2017)
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium
Rolando Cannalire et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109
Gerjo J. de Knegt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
MmpS5/MmpL5 as an efflux pump in Mycobacterium species
Julien Briffotaux et al.
TUBERCULOSIS (2017)
Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery
Dirk Bald et al.
MBIO (2017)
Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan
Kao-Chi Cheng et al.
FRONTIERS IN PHARMACOLOGY (2017)
Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil
Jeevan M. Puthiamadathil et al.
CANCER MANAGEMENT AND RESEARCH (2017)
Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis
Mashael Al-Saeedi et al.
INFECTION AND DRUG RESISTANCE (2017)
The mechanisms of action of metformin
Graham Rena et al.
DIABETOLOGIA (2017)
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein et al.
BLOOD (2017)
Antituberculosis drugs: reducing efflux = increasing activity
Liliana Rodrigues et al.
DRUG DISCOVERY TODAY (2017)
Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy
Caroline M. Pule et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Thioridazine in PLGA nanoparticles reduces toxicity and improves rifampicin therapy against mycobacterial infection in zebrafish
Carina Beatrice Vibe et al.
NANOTOXICOLOGY (2016)
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2016)
Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
Deepak Almeida et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria
Sofia Santos Costa et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2016)
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules
Haim Ashkenazy et al.
NUCLEIC ACIDS RESEARCH (2016)
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions
Christian Lienhardt et al.
PLOS MEDICINE (2016)
Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis
Diana Machado et al.
PLOS ONE (2016)
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives
Johanna Mondesir et al.
JOURNAL OF BLOOD MEDICINE (2016)
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatment
Geetha Srikrishna et al.
FUTURE MICROBIOLOGY (2015)
Study of efflux pump gene expression in rifampicin-monoresistant Mycobacterium tuberculosis clinical isolates
Guilian Li et al.
JOURNAL OF ANTIBIOTICS (2015)
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy
Marco Pieroni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Homologs of the Acinetobacter baumannii AceI Transporter Represent a New Family of Bacterial Multidrug Efflux Systems
Karl A. Hassan et al.
MBIO (2015)
Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
Jan Rybniker et al.
NATURE COMMUNICATIONS (2015)
In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni
Bruno J. Neves et al.
PLOS NEGLECTED TROPICAL DISEASES (2015)
Recent advances toward a molecular mechanism of efflux pump inhibition
Timothy J. Opperman et al.
FRONTIERS IN MICROBIOLOGY (2015)
The Efflux Pump Inhibitor Timcodar Improves the Potency of Antimycobacterial Agents
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion
Mark Schiebler et al.
EMBO MOLECULAR MEDICINE (2015)
Antimycobacterial activity of DNA intercalator inhibitors of Mycobacterium tuberculosis primase DnaG
Chathurada Gajadeera et al.
JOURNAL OF ANTIBIOTICS (2015)
In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib
Michael G. Rolf et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
Shashank Gupta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
Ruben C. Hartkoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis
Philippa A. Black et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Acid suppressive agents and risk of Mycobacterium Tuberculosis: case-control study
Wen-Hung Hsu et al.
BMC GASTROENTEROLOGY (2014)
Verapamil, and Its Metabolite Norverapamil, Inhibit Macrophage-induced, Bacterial Efflux Pump-mediated Tolerance to Multiple Anti-tubercular Drugs
Kristin N. Adams et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Ofloxacin Resistance in Mycobacterium tuberculosis Is Associated with Efflux Pump Activity Independent of Resistance Pattern and Genotype
Zhaogang Sun et al.
MICROBIAL DRUG RESISTANCE (2014)
A Trisubstituted Benzimidazole Cell Division Inhibitor with Efficacy against Mycobacterium tuberculosis
Susan E. Knudson et al.
PLOS ONE (2014)
Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
Koen Andries et al.
PLOS ONE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Common Drugs Inhibit Human Organic Cation Transporter 1 (OCT1)-Mediated Neurotransmitter Uptake
Kelli H. Boxberger et al.
DRUG METABOLISM AND DISPOSITION (2014)
Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor
Shashank Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Study of the Rifampin Monoresistance Mechanism in Mycobacterium tuberculosis
Yu Pang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
Liliana Rodrigues et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies
Muhammad Baluom et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
The Mycobacterium tuberculosis Secreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11
Cedric P. Owens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Systematic In Silico Search for Target Similarity Identifies Several Approved Drugs with Potential Activity against the Plasmodium falciparum Apicoplast
Nadlla Alves Bispo et al.
PLOS ONE (2013)
Levoleucovorin as Replacement for Leucovorin in Cancer Treatment
Victor Tuan Giam Chuang et al.
ANNALS OF PHARMACOTHERAPY (2012)
Functional and Genetic Characterization of the Tap Efflux Pump in Mycobacterium bovis BCG
Santiago Ramon-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Efflux Pumps of Mycobacterium tuberculosis Play a Significant Role in Antituberculosis Activity of Potential Drug Candidates
Meenakshi Balganesh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance
Aurelia M. Schmalstieg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
Cristian Varela et al.
CHEMISTRY & BIOLOGY (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs
Miguel Viveiros et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex
Liliana Rodrigues et al.
INFECTION GENETICS AND EVOLUTION (2012)
Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms
Prema S. Rao et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
Eduardo Abbate et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
Diana Machado et al.
PLOS ONE (2012)
Efflux Pump-Mediated Resistance in Chemotherapy
P. O. Ughachukwu et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2012)
Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux
Gail E. Louw et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism
Kristin N. Adams et al.
CELL (2011)
A new evolutionary and pharmacokinetic-pharmacodynamic scenario for rapid emergence of resistance to single and multiple anti-tuberculosis drugs
Jotam G. Pasipanodya et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs
Pedro Eduardo Almeida Da Silva et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Discovery and characterization of a unique mycobacterial heme acquisition system
Michael V. Tullius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomes
Adamandia Kapopoulou et al.
TUBERCULOSIS (2011)
Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery
Meenakshi Balganesh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Emergence and Molecular Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from the Delhi Region in India
Alka Khanna et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation
David J. Sweeny et al.
DRUG METABOLISM AND DISPOSITION (2010)
Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections
Miguel Viveiros et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis
Sandeep Sharma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Efflux-Pump-Derived Multiple Drug Resistance to Ethambutol Monotherapy in Mycobacterium tuberculosis and the Pharmacokinetics and Pharmacodynamics of Ethambutol
Shashikant Srivastava et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs
Anuj Kumar Gupta et al.
MICROBIAL DRUG RESISTANCE (2010)
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
G. E. Louw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth
Santiago Ramon-Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Mechanisms of drug efflux and strategies to combat them: Challenging the efflux pump of Gram-negative bacteria
Jean-Marie Pages et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Is Levoleucovorin an Alternative to Racemic Leucovorin? A Literature Review
Philip A. Kovoor et al.
CLINICAL COLORECTAL CANCER (2009)
New Developments in Anthracycline-Induced Cardiotoxicity
A. Mordente et al.
CURRENT MEDICINAL CHEMISTRY (2009)
The role of efflux pumps in macrolide resistance in Mycobacterium avium complex
Liliana Rodrigues et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Sarah Shugarts et al.
PHARMACEUTICAL RESEARCH (2009)
Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system
Anna Milano et al.
TUBERCULOSIS (2009)
Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis
Olga Danilchanka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis
Doris Lechner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Thioridazine and chlorpromazine inhibition of ethidium bromide efflux in Mycobacterium avium and Mycobacterium smegmatis
Liliana Rodrigues et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?
G. Rosenberg
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps
Leonard Amaral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
S. S. Lund et al.
DIABETES OBESITY & METABOLISM (2007)
Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG
Santiago Ramon-Garcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Ouabain binds with high affinity to the Na,K-ATPase in human polycystic kidney cells and induces extracellular signal-regulated kinase activation and cell proliferation
Anh-Nguyet T. Nguyen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
LJV Piddock
CLINICAL MICROBIOLOGY REVIEWS (2006)
Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use
O Lomovskaya et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum
S Ramón-García et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder
RP Bazinet et al.
PSYCHOPHARMACOLOGY (2006)
Digitalis: new actions for an old drug
JA Wasserstrom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis
MR Pasca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibition of P-glycoprotein by natural products in human breast cancer cells
SY Chung et al.
ARCHIVES OF PHARMACAL RESEARCH (2005)
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance
P Domenech et al.
INFECTION AND IMMUNITY (2005)
Inhibitors of type IINADH:-menaquinone oxidoreductase represent a class of antitubercular drugs
EA Weinstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol
R Colangeli et al.
MOLECULAR MICROBIOLOGY (2005)
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis
K Andries et al.
SCIENCE (2005)
Rv2686c-rv2687c-rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis
MR Pasca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis
XZ Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus
C Seral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
The multidrug transporters belonging to major facilitator superfamily (MFS) in Mycobacterium tuberculosis
E De Rossi et al.
MOLECULAR MEDICINE (2002)
Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis
BS Choudhuri et al.
BIOCHEMICAL JOURNAL (2002)
Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis
M Viveiros et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Effect of anesthetic gases on the growth of Pseudomonas aeruginosa, Haemophilus influenzae, and Staphylococcus aureus
A A-Rahman et al.
PEDIATRIC PULMONOLOGY (2002)
Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis
PEA Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Effect of proton pump inhibitor alone or in combination with clarithromycin on mycobacterial growth in human alveolar macrophages
K Suzuki et al.
FEMS MICROBIOLOGY LETTERS (2000)
分享论文
